Literature DB >> 2992304

High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis.

P D Marsden, R N Sampaio, E M Carvalho, J P Veiga, J L Costa, E A Llanos-Cuentas.   

Abstract

The treatment of two patients with severe mucosal leishmaniasis due to Leishmania braziliensis braziliensis is described. Both patients had received much prior antimonial therapy and one had relapsed after a total dose of 2.5 g of Amphotericin B. Both patients responded to prolonged continuous Pentostam therapy at a daily dose of 20 mg Sbv/kg/day for 62 days in one case and for 85 days in the other. Pentavalent antimonials can be curative in such protracted courses in selected patients unresponsive to standard chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2992304     DOI: 10.4269/ajtmh.1985.34.710

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  2 in total

1.  Rural campaign to diagnose and treat mucocutaneous leishmaniasis in Bolivia.

Authors:  J P Dedet; R Melogno; F Cardenas; L Valda; C David; V Fernandez; M E Torrez; L Dimier-David; P Lyevre; M E Villareal
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

Review 2.  A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity.

Authors:  Zahra Nasiri-Toosi; Simin Dashti-Khavidaki; Hossein Khalili; Mahboob Lessan-Pezeshki
Journal:  Eur J Clin Pharmacol       Date:  2012-11-22       Impact factor: 2.953

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.